Yazar "Pak, Ceren D." için listeleme
-
68-months progression-free survival with crizotinib treatment in a patient with metastatic ALK positive lung adenocarcinoma and sarcoidosis: A case report
Tanrıverdi, Özgür; Tarımer, Mehmet L.; Pak, Ceren D.; Uylaş, Selcuk; Alkan, Ali; Çelik, Özgur İlhan; Zeybek, Arife; Kılıç, Rabia M. (Sage Publications Ltd, 2020)Introduction Lung cancer still ranks first among the most common and most lethal cancers today. The most common subtype is non-small cell lung cancer, and in this group, adenocarcinoma has the worst prognosis. EGFR, ROS1 ...
